Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs
(1) Background: Mopeia–Lassa reassortant ML29 virus is an investigational, reassortant virus vaccine for the prevention of Lassa fever caused by Lassa virus (LASV). (2) Methods: The vaccine virus ML29-SF was prepared in Vero cells using a serum-free culture medium under Good Manufacturing Practice....
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2025-05-01
|
| Saila: | Future Pharmacology |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2673-9879/5/2/26 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|